Bui KC - Search Results

1

Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth.

Nguyen MLT, Pham C, Pham VT, Nham PLT, Ta BT, Le DT, Le QV, Hoang XC, Bozko P, Nguyen LT, Bui KC. Nguyen MLT, et al. Among authors: bui kc. Cell Biochem Biophys. 2024 Jan 20. doi: 10.1007/s12013-024-01217-9. Online ahead of print. Cell Biochem Biophys. 2024. PMID: 38243102

2

Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.

Müller A, Barat S, Chen X, Bui KC, Bozko P, Malek NP, Plentz RR. Müller A, et al. Among authors: bui kc. Int J Oncol. 2016 May;48(5):2025-34. doi: 10.3892/ijo.2016.3411. Epub 2016 Mar 1. Int J Oncol. 2016. PMID: 26935541

3

Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.

Chen X, Bui KC, Barat S, Thi Nguyen ML, Bozko P, Sipos B, Kalesse M, Malek NP, Plentz RR. Chen X, et al. Among authors: bui kc. Cancer Lett. 2017 Jul 28;399:20-28. doi: 10.1016/j.canlet.2017.04.003. Epub 2017 Apr 10. Cancer Lett. 2017. PMID: 28408354

4

Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma.

Bui KC, Barat S, Chen X, Bozko P, Scholta T, Nguyen MLT, Bhuria V, Xing J, Nguyen LT, Le HS, Velavan TP, Sipos B, Wilkens L, Malek NP, Plentz RR. Bui KC, et al. Exp Cell Res. 2018 Mar 1;364(1):59-67. doi: 10.1016/j.yexcr.2018.01.028. Epub 2018 Jan 31. Exp Cell Res. 2018. PMID: 29366806

5

Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma.

Bhuria V, Xing J, Scholta T, Bui KC, Nguyen MLT, Malek NP, Bozko P, Plentz RR. Bhuria V, et al. Among authors: bui kc. Exp Cell Res. 2019 Dec 15;385(2):111671. doi: 10.1016/j.yexcr.2019.111671. Epub 2019 Oct 18. Exp Cell Res. 2019. PMID: 31634481

6

Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition.

Xing J, Bhuria V, Bui KC, Nguyen MLT, Hu Z, Hsieh CJ, Wittstein K, Stadler M, Wilkens L, Li J, Kalesse M, Bozko P, Plentz RR. Xing J, et al. Among authors: bui kc. Cancers (Basel). 2020 Mar 6;12(3):615. doi: 10.3390/cancers12030615. Cancers (Basel). 2020. PMID: 32155915 Free PMC article.

7

Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.

Nguyen MLT, Bui KC, Scholta T, Xing J, Bhuria V, Sipos B, Wilkens L, Nguyen Linh T, Velavan TP, Bozko P, Plentz RR. Nguyen MLT, et al. Among authors: bui kc. J Gastroenterol Hepatol. 2021 May;36(5):1334-1345. doi: 10.1111/jgh.15307. Epub 2020 Nov 12. J Gastroenterol Hepatol. 2021. PMID: 33091158

8

Cholangiocarcinoma Therapeutics: An Update.

Nguyen MLT, Toan NL, Bozko M, Bui KC, Bozko P. Nguyen MLT, et al. Among authors: bui kc. Curr Cancer Drug Targets. 2021;21(6):457-475. doi: 10.2174/1568009621666210204152028. Curr Cancer Drug Targets. 2021. PMID: 33563168 Review.

9

The safety of CAR-T cells and PD-1 antibody combination on an experimental model.

Nguyen HH, Bui KC, Nguyen TML, Pham C, Nham TPL, Ngo TH, Ho VH, Ta VH, Bozko P, Nguyen LT, Can VM. Nguyen HH, et al. Among authors: bui kc. Biochem Biophys Res Commun. 2023 Mar 15;649:25-31. doi: 10.1016/j.bbrc.2023.01.096. Epub 2023 Jan 31. Biochem Biophys Res Commun. 2023. PMID: 36739696

10

The diagnostic and prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on gastric cancer patients.

Nguyen MLT, Pham C, Le QV, Nham PLT, Tran DH, Le TS, Hoang VT, Can VM, Nguyen LT, Bui KC. Nguyen MLT, et al. Among authors: bui kc. Medicine (Baltimore). 2023 Aug 4;102(31):e34357. doi: 10.1097/MD.0000000000034357. Medicine (Baltimore). 2023. PMID: 37543797 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page